Opposing associations of muscle and fat mass changes on serum uric acid levels: a 2-year longitudinal cohort study

Read full text
Authors: Jiwon Hwang, Mi Jung Lee, Joong Kyong Ahn
Cited by: 1
References: 31

Abstract

BACKGROUND/AIMS: Obesity elevates serum uric acid (SUA) levels, but the influence of muscle mass remains unclear. As a major endogenous purine pool, skeletal muscle may affect SUA dynamics. We evaluated the impact of changes in body components, including skeletal muscle mass index (SMI), fat mass index (FMI), and waist-to-hip ratio (WHR), on SUA in a large cohort of healthy Koreans. METHODS: We analyzed 39,505 adults (24,623 men; 14,180 premenopausal and 702 postmenopausal women) who underwent health checkups in 2015-2017. Body composition was assessed using bioimpedance analysis. Participants were categorized into seven groups based on 2-year changes in SMI, FMI, and WHR (tertiles of increase, decrease, and no change). Hyperuricemia was defined as SUA ≥ 7 mg/dL in men and ≥ 6 mg/dL in women. Odds ratios (ORs) for achieving optimal SUA levels (< 6 mg/dL) and regression coefficients for SUA changes were calculated. RESULTS: Mean SUA levels were 6.25 ± 1.21 mg/dL in men, 4.23 ± 0.88 mg/dL in premenopausal women, and 4.34 ± 0.91 mg/dL in postmenopausal women. SUA changed dose-dependently with body component: SMI increases were associated with reduced SUA (OR [95% CI] for the highest tertile = 1.45 [1.32-1.59] in men; 1.48 [1.06-2.06] in premenopausal women), while FMI and WHR increases correlated positively with SUA. CONCLUSION: Two-year changes in body composition significantly influenced SUA levels, particularly in men and premenopausal women. Increasing muscle mass and reducing adiposity may be associated with improved urate control in individuals with hyperuricemia or those prone to gout.

Fields of Study & Subjects

Gout Hyperuricemia Uric Acid Sodium Intake and Health Diet Metabolism and Disease

Publication details

Journal / source
The Korean Journal of Internal Medicine
Publisher
Korean Association of Internal Medicine
Volume
41
Issue
3
Pages
537–554
Publication date
30 April 2026
Language
EN